Viktor Dahl

2.5k total citations
21 papers, 1.0k citations indexed

About

Viktor Dahl is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Viktor Dahl has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Viktor Dahl's work include HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (10 papers) and HIV/AIDS drug development and treatment (5 papers). Viktor Dahl is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS Research and Interventions (10 papers) and HIV/AIDS drug development and treatment (5 papers). Viktor Dahl collaborates with scholars based in Sweden, United States and Australia. Viktor Dahl's co-authors include Sarah Palmer, Lina Josefsson, Richard W. Price, Julia Peterson, Dietmar Fuchs, Magnus Gisslén, Barbara L. Shacklett, Peter W. Hunt, Elizabeth Sinclair and Jeffrey N. Martin and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Viktor Dahl

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viktor Dahl Sweden 14 699 612 269 231 141 21 1.0k
Jean-Louis Sankalé United States 20 802 1.1× 752 1.2× 297 1.1× 114 0.5× 122 0.9× 29 1.1k
Ramu Sarge‐Njie Gambia 21 634 0.9× 706 1.2× 352 1.3× 153 0.7× 237 1.7× 31 1.1k
Duncan Chege Canada 14 437 0.6× 332 0.5× 213 0.8× 116 0.5× 430 3.0× 21 885
Sandra Emery United States 16 489 0.7× 512 0.8× 273 1.0× 87 0.4× 119 0.8× 21 893
Omu Anzala Kenya 18 653 0.9× 653 1.1× 407 1.5× 47 0.2× 286 2.0× 54 1.1k
Luis Enrique Soto-Ramírez Mexico 15 532 0.8× 513 0.8× 236 0.9× 70 0.3× 122 0.9× 43 822
Zhong-Min Ma United States 12 686 1.0× 383 0.6× 263 1.0× 69 0.3× 383 2.7× 15 907
Dana Panteleeff United States 14 989 1.4× 1.0k 1.7× 482 1.8× 100 0.4× 227 1.6× 16 1.4k
Shlomo Maayan Israel 18 507 0.7× 670 1.1× 340 1.3× 39 0.2× 69 0.5× 74 1.1k
Vicharn Vithayasai Thailand 11 430 0.6× 627 1.0× 335 1.2× 87 0.4× 136 1.0× 31 948

Countries citing papers authored by Viktor Dahl

Since Specialization
Citations

This map shows the geographic impact of Viktor Dahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Dahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Dahl more than expected).

Fields of papers citing papers by Viktor Dahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Dahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Dahl. The network helps show where Viktor Dahl may publish in the future.

Co-authorship network of co-authors of Viktor Dahl

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Dahl. A scholar is included among the top collaborators of Viktor Dahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Dahl. Viktor Dahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colombe, Soledad, Maria Axelsson, Soo Aleman, et al.. (2022). Monitoring the progress towards the elimination of hepatitis B and C in Sweden: estimation of core indicators for 2015 and 2018. BMC Infectious Diseases. 22(1). 885–885. 3 indexed citations
2.
Dahl, Viktor, Ammar Majeed, Agneta Wikman, Rut Norda, & Gustaf Edgren. (2020). Transmission of viral hepatitis through blood transfusion in Sweden, 1968 to 2012. Eurosurveillance. 25(29). 5 indexed citations
3.
Dahl, Viktor, Karin Tegmark Wisell, Christian G. Giske, Anders Tegnell, & Anders Wallensten. (2019). Lyme neuroborreliosis epidemiology in Sweden 2010 to 2014: clinical microbiology laboratories are a better data source than the hospital discharge diagnosis register. Eurosurveillance. 24(20). 21 indexed citations
4.
Edgren, Gustaf, Helle Hjalgrim, Klaus Rostgaard, et al.. (2018). Searching for unknown transfusion‐transmitted hepatitis viruses: a binational cohort study of 1.5 million transfused patients. Journal of Internal Medicine. 284(1). 92–103. 7 indexed citations
5.
Dahl, Viktor, Lena Sundqvist, Ingela Hedenström, et al.. (2017). A nationwide outbreak of listeriosis associated with cold-cuts, Sweden 2013-2014. Infection Ecology & Epidemiology. 7(1). 1324232–1324232. 13 indexed citations
6.
Dahl, Viktor, et al.. (2017). Multi-country outbreak of Salmonella enteritidis infection linked to the international ice hockey tournament. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
7.
Dahl, Viktor & Anders Wallensten. (2017). Self-reported infections during international travel and notifiable infections among returning international travellers, Sweden, 2009-2013. PLoS ONE. 12(7). e0181625–e0181625. 10 indexed citations
8.
Dahl, Viktor, et al.. (2017). Multi-country outbreak ofSalmonella enteritidisinfection linked to the international ice hockey tournament. Epidemiology and Infection. 145(11). 2221–2230. 13 indexed citations
9.
Dahl, Viktor, Anders Tegnell, & Anders Wallensten. (2015). Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013. PLoS ONE. 10(9). e0136353–e0136353. 13 indexed citations
10.
Dahl, Viktor, Julia Peterson, Dietmar Fuchs, et al.. (2014). Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS. 28(15). 2251–2258. 114 indexed citations
11.
Hunt, Peter W., Nancy S. Shulman, Timothy L. Hayes, et al.. (2013). The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood. 121(23). 4635–4646. 107 indexed citations
12.
Dahl, Viktor, Magnus Gisslén, Lars Hagberg, et al.. (2013). An Example of Genetically Distinct HIV Type 1 Variants in Cerebrospinal Fluid and Plasma During Suppressive Therapy. The Journal of Infectious Diseases. 209(10). 1618–1622. 41 indexed citations
13.
Dahl, Viktor, Julia Peterson, Serena Spudich, et al.. (2012). Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers. AIDS. 27(7). 1145–1149. 15 indexed citations
14.
Dahl, Viktor, Evelyn Lee, Julia Peterson, et al.. (2011). Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy. The Journal of Infectious Diseases. 204(12). 1936–1945. 55 indexed citations
15.
Gutiérrez, Carolina, Laura Díaz, Alejandro Vallejo, et al.. (2011). Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected. PLoS ONE. 6(12). e27864–e27864. 82 indexed citations
16.
Hatano, Hiroyu, Timothy L. Hayes, Viktor Dahl, et al.. (2011). A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response. The Journal of Infectious Diseases. 203(7). 960–968. 153 indexed citations
17.
Josefsson, Lina, Viktor Dahl, & Sarah Palmer. (2010). Can HIV infection be eradicated through use of potent antiviral agents?. Current Opinion in Infectious Diseases. 23(6). 628–632. 12 indexed citations
18.
Dahl, Viktor, Lina Josefsson, & Sarah Palmer. (2009). HIV reservoirs, latency, and reactivation: Prospects for eradication. Antiviral Research. 85(1). 286–294. 89 indexed citations
19.
Dahl, Viktor, Lisa Mellhammar, Francis Bajunirwe, & Per Björkman. (2008). Acceptance of HIV testing among women attending antenatal care in south-western Uganda: risk factors and reasons for test refusal. AIDS Care. 20(6). 746–752. 49 indexed citations
20.
Silins, Ilvars, Walter Ryd, Anders Strand, et al.. (2005). Chlamydia trachomatis infection and persistence of human papillomavirus. International Journal of Cancer. 116(1). 110–115. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Louis Sankalé Breakdown of academic impact, for papers by Ramu Sarge‐Njie Breakdown of academic impact, for papers by Duncan Chege Breakdown of academic impact, for papers by Sandra Emery Breakdown of academic impact, for papers by Omu Anzala Breakdown of academic impact, for papers by Luis Enrique Soto-Ramírez Breakdown of academic impact, for papers by Zhong-Min Ma Breakdown of academic impact, for papers by Dana Panteleeff Breakdown of academic impact, for papers by Shlomo Maayan Breakdown of academic impact, for papers by Vicharn Vithayasai
Rankless by CCL
2026